UNITED STATES | CHANGE COUNTRY
MY ACCOUNT | ORDER STATUS

MP News

[2010-03-09] MP Biomedicals Launches World's First Anti-Dengue IgA Rapid Test in Singapor & Online Dengue Information Center (www.mpDengueinfo.com)

Singapore, March 1st 2010 – MP Biomedicals announced the launch of ASSURE® Dengue IgA Rapid Test. This assay is a reverse flow immunochromatographic rapid test for qualitative detection of anti-dengue IgA antibody in human samples (serum, whole blood and plasma) which not only increases the sensitivity of the technique but also make the test useful at the acute phase of infection at any level of health care system (Sil et al., 2007). The test was found to detect more dengue positive cases during acute stage of infection compared to other dengue diagnostic tools available in the market.

Please click here to read the full press release.

Or, click here to visit the Dengue Info website.

 

[2009-11-02] MP Biomedicals CEO Addresses Students at Peking University, Beijing, China

Milan Panic, the CEO of MP Biomedicals, was invited to speak before hundreds of students at Peking University in Beijing, China on October 23, 2009. His speech titled, "Science Makes Legends", reflected on Mr, Panic's life and achievements. The young people in the audience were encouraged to have dreams and to work at achieving their dreams. Mr. Panic told the students that this is an unprecedented time in history to be involved in scientific study and research.


Please click here to read the full article which was published by the Global Times, Beijing, China

 

[2009-06-23] Isolate Influenza Virus Particles Using FastPrep-24:

The department of Virology of the Erasmus Medical Center in Rotterdam, Netherlands, has successfully optimized the isolation of Influenza A / H3N2 viruses from murine lung tissues by using  the FastPrep-24 instrument.  These astonishing results were published in the peer-reviewed PLoS ONE publication; Bodewes R, Kreijtz JHCM, Baas C, Geelhoed-Mieras MM, de Mutsert G, et al. 2009, Vaccination Against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity Against Lethal Infection with Avian Influenza A/H5N1 Virus. PLoS ONE 4(5): e5538 . doi:10.1371/journal.pone.0005538.  

MP Biomedicals has released a condensed protocol for whole viral particles isolation using the FastPrep-24 system and lysing matrices. Click the link to download a copy of this protocol.  For further questions or information regarding the FastPrep-24 or this protocol, please contact  one of our molecular biology experts by email: fp@mpbio.com

 

[2009-06-23] MP Biomedicals Exhibits at AACC Clinical Lab Expo, July 19 - 23, 2009

Santa Ana, CA, June 10, 2009 - MP Biomedicals, LLC, a global diagnostics supplier,  will be participating in the upcoming AACC Clinical Lab Expo to be held July 19-23, 2009 at McCormick Place in Chicago. The company's exhibit will feature key products of it's worldwide diagnostic line,  including Western Blot, ELISA, and Rapid Tests for infectious diesease, virology, endocrinology, food quality  testing, fertility, and drugs-of-abuse.  Additionally, MP will feature it's signature  FastPrep-24 System for DNA, RNA and Protein isolation. Featured offerings include the HIV 2.2 WB, HTLV 4.0 Elisa, HEV Elisa IgG, Dengue IgA Rapid Test, the FDA cleared  Rapid Drugs-of Abuse line, and a complete line for HEV screening and confirmation. To find out more about all MP Diagnostic products, plan to visit booth # 4253 at AACC in Chicago or visit the company's  website: www.mpbio.com.

Source: MP Biomedicals

 


Featured Lab
Free samples and promotions
MP Genesis New Lab Startup Program

 

 

 
1